Search

Your search keyword '"Wiangnon S"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Wiangnon S" Remove constraint Author: "Wiangnon S"
129 results on '"Wiangnon S"'

Search Results

1. International incidence of childhood cancer, 2001–10: a population-based registry study

2. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

3. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

4. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

7. Erratum to 'The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)' [Gynecol. Oncol. 144 (2017) 405-413]

8. International incidence of childhood cancer, 2001-10 a population-based registry study

9. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

10. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

11. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

12. Erratum to 'Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)' [Gynecol. Oncol. 144 (2017) 396–404]

13. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

14. International incidence of childhood cancer, 2001-10: a population-based registry study.

15. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

16. International incidence of childhood cancer, 2001–10: a population-based registry study

17. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

18. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

20. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

21. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413]

22. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404]

23. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: Evidence from the Breast Cancer Association Consortium

24. 19p13.1 Is a triple-negative-specific breast cancer susceptibility locus

25. 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

26. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers

27. Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers

30. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

37. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

38. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women

39. The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population

40. Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand.

41. Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.

43. Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.

44. Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011.

45. Opisthorchiasis with proinflammatory cytokines (IL-1β and TNF-α) polymorphisms influence risk of intrahepatic cholangiocarcinoma in Thailand: a nested case-control study.

46. Breast Cancer Incidence Trends and Projections in Northeastern Thailand.

47. Fetal Anemia Causing Hydrops Fetalis From an Alpha-Globin Variant: Homozygous Hemoglobin Constant Spring.

48. Risk Factors for Cholangiocarcinoma in Thailand: A Systematic Review and Meta-Analysis

49. Lupus Anticoagulant-hypoprothrombinemia Syndrome (LAC-HPS) in Children With Systemic Lupus Erythematosus: Report of 3 Cases.

50. The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospital-based matched case-control study.

Catalog

Books, media, physical & digital resources